Key facts
- VANGUARD GROUP INC filed SCHEDULE 13G/A for Ironwood Pharmaceuticals Inc Common Stock (IRWD).
- Disclosed ownership: 12%.
- Date of event: 31 Dec 2024.
VANGUARD GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for Ironwood Pharmaceuticals Inc Common Stock (IRWD)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Symbol
- IRWD
- Shares outstanding
- 160,152,090 shares
- Disclosed Ownership
- 19,538,555 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13G/A
- Filing time
- 31 Jan 2025, 11:44:22 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 30 Apr 2025
- SEC
- View on sec.gov
Key filing fact
VANGUARD GROUP INC disclosed 12% ownership in Ironwood Pharmaceuticals Inc Common Stock (IRWD) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 31 Jan 2025, 11:44.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 12% | 19,538,555 | 0 | 458,561 | Ashley Grim | Head of Global Fund Administration |
CIK / CUSIP context first